Trade Mark 2491996 | IP Australia

Advanced search

Number: 2491996

IR number: 1813039

Words: SYNTEIN
Status: protected: Registered/protected
Priority date: 31 Oct 2023 (Convention)
Classes: 1, 5, 40, 42
Kind: Word

SYNTEIN

Goods & Services

Class 1:: Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research.

Class 5:: Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; all of the aforementioned items not being for or including pharmaceutical intravenous natural (or canonical) amino acid solutions that provide nutritional support in healthcare settings.

Class 40:: Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use.

Class 42:: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides.

Convention details

Date:

31 Oct 2023

Number:

98248592

Country:

UNITED STATES OF AMERICA

Opposition details

Commenced on: 02 Jun 2025
Type: Opposition to registration
Final outcome: Discontinued
Opponent: Baxter International Inc. a Delaware corporation; Open details

History and Publications

Date	Description
29 Aug 2026	International Registration in Australia Protected correspondence sent
28 Aug 2026	International Registration in Australia Protected correspondence sent
28 Aug 2026	Opposition Withdrawn Notice (IRDA Defendant) correspondence sent
28 Aug 2026	Opposition Withdrawn Notice (Opponent) correspondence sent
28 Aug 2026	IP Right Registration Published	Trade mark details »
28 Aug 2026	Status change to Registered/Protected
27 Aug 2026	Withdrawal of a Dispute Requested
26 Aug 2026	General Dispute correspondence sent
26 Aug 2026	General Dispute correspondence sent
26 Aug 2026	IP right goods and service classes updated	More
	Event description Class Count: 4 Class Numbers:1; 5; 40; 42 Previous details Class Count: 4 Class Numbers: 1; 5; 40; 42 New details Class Count: 4 Class Numbers: 1; 5; 40; 42
26 Aug 2026	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details Class Number: 5 Class Items: Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use. New details Class Number: 5 Class Items: Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; all of the aforementioned items not being for or including pharmaceutical intravenous natural (or canonical) amino acid solutions that provide nutritional support in healthcare settings.
13 May 2026	General Dispute correspondence sent
13 May 2026	General Dispute correspondence sent
13 May 2026	General Dispute correspondence sent
11 May 2026	General Dispute Correspondence Received
05 May 2026	Cooling Off Extension Requested correspondence sent
05 May 2026	Cooling Off Extension Requested correspondence sent
04 May 2026	Cooling Off Period Requested
11 Nov 2025	Cooling Off Requested correspondence sent
11 Nov 2025	Cooling Off Requested correspondence sent
11 Nov 2025	Cooling Off Requested correspondence sent
11 Nov 2025	Cooling Off Requested correspondence sent
05 Nov 2025	Cooling Off Period Requested
11 Oct 2025	IRDA - Opposition Still Possible Notice correspondence sent
19 Aug 2025	Intention to Defend Filed Notice (IRDA Defendant) correspondence sent
19 Aug 2025	Intention to Defend Filed Notice (Opponent) correspondence sent
14 Aug 2025	Notice of Intention to Defend Received
28 Jul 2025	Customer Amendment Made correspondence sent
28 Jul 2025	Customer Amendment Made correspondence sent
28 Jul 2025	General Dispute correspondence sent
28 Jul 2025	General Dispute Correspondence Received
25 Jul 2025	Amendment to Address for Service Requested
15 Jul 2025	General Dispute correspondence sent
15 Jul 2025	Grounds and Particulars Filed Notice (IRDA Defendant) correspondence sent
15 Jul 2025	Grounds and Particulars Filed Notice (Opponent) correspondence sent
15 Jul 2025	General Dispute correspondence sent
14 Jul 2025	Amendment During Opposition Received
07 Jul 2025	General Dispute correspondence sent
01 Jul 2025	Statement of Grounds and Particulars Received
05 Jun 2025	Intention to Oppose Filed Notice (IRDA Defendant) correspondence sent
05 Jun 2025	Intention to Oppose Filed Notice (Opponent) correspondence sent
02 Jun 2025	Notice of Intention to Oppose Registration Received
03 Apr 2025	Application Accepted correspondence sent
02 Apr 2025	Corrigenda Published	Trade mark details » More
	Details Goods amended by adding class 5 and transferring “Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use” to that class from class 1, as they were incorrectly classified.
02 Apr 2025	IP Right has been Examined
02 Apr 2025	IP Right Acceptance Published	Trade mark details »
02 Apr 2025	Status change to Accepted
02 Apr 2025	IP right goods and service classes updated	More
	Event description Class Count: 4 Class Numbers:1; 5; 40; 42 Previous details Class Count: 3 Class Numbers: 1; 40; 42 New details Class Count: 4 Class Numbers: 1; 5; 40; 42
02 Apr 2025	IP Right Goods and Services Items updated	More
	Event description Class Number: 1 Previous details Class Number: 1 Class Items: Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use. New details Class Number: 1 Class Items: Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research.
02 Apr 2025	IP Right Goods and Services Items updated	More
	Event description Class Number: 5 Previous details New details Class Number: 5 Class Items: Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use.
27 Mar 2025	International Registration - Correction Received
23 Oct 2024	Examination expedited
23 Oct 2024	Awaiting examination
23 Oct 2024	Corrigenda Published	Trade mark details » More
	Details Application publication should reflect IR Number 1813039.
23 Oct 2024	IP Right Filed Published	Trade mark details »
23 Oct 2024	Status change to Published
23 Oct 2024	Status change to Filed
23 Oct 2024	IP right goods and service classes updated	More
	Event description Class Count: 3 Class Numbers:1; 40; 42 Previous details Class Count: 0 Class Numbers: New details Class Count: 3 Class Numbers: 1; 40; 42
23 Oct 2024	IP Right Goods and Services Items updated	More
	Event description Class Number: 40 Previous details New details Class Number: 40 Class Items: Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use.
23 Oct 2024	IP Right Goods and Services Items updated	More
	Event description Class Number: 42 Previous details New details Class Number: 42 Class Items: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides.
23 Oct 2024	IP Right Goods and Services Items updated	More
	Event description Class Number: 1 Previous details New details Class Number: 1 Class Items: Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use.
23 Oct 2024	Trade mark representation updated
21 Oct 2024	Application Received
21 Oct 2024	Status change to Received

Dates

Renewal due: 29 Apr 2034
Registration advertised / published: 28 Aug 2026
Entered on Register: 28 Aug 2026
Acceptance advertised / published: 02 Apr 2025
Acceptance: 02 Apr 2025
IR notification: 10 Oct 2024
Filing: 29 Apr 2024
Registered from: 29 Apr 2024

Owner

Address for service

IR Contact

Indexing constituents

Word

SYNTEIN

Image

Australian Trade Mark Search

Goods & Services

Convention details

Opposition details

History and Publications

Dates

Owner

Address for service

IR Contact

Indexing constituents